Case Report A 55 years old gentleman, previously healthy male presented with a seven day history of gradual swelling and pain in the left lower limb. Pain was located over whole limb associated with redness, increased temperature and dilatation of the superficial veins. The pain was aggravated by sitting ,immediately after walking for certain distance and rest being the only relieving factor. The patient's sleep was disturbed, particularly lying on the affected side. The patient's past medical history revealed similar event of swelling of his left leg 1 year ago which had been treated successfully. In the patient's history, there were no history of hypertension, recent major surgery, immobilization or occurrence of any serious medical conditions. On physical examination,he had no abnormalities except swollen left lower limb. Local examination of left lower limb revealed , skin redness, swelling engorged superficial veins,mild tenderness and increased temperature over whole limb. All lower extremity pulses were present and of equal volume in both sides and there were no digital ischemia. 
Discussion
Deep venous thrombosis defined as a partial or complete occlution of a deep vein by thrombus, is a relatively uncommon yet important diagnosis in primary care practice. 6, 7 The common clinical presentation of the venous thrombo-embolic disease (VTE) is with deep vein thrombosis of the leg and /or pulmonary embolism. 8 Risk factors of DVT include past history of deep vein thrombosis, pulmonary oedema, operative intervention, immobilization, trauma, neurological deficit, malignancies, sepsis, central venus catheter and hyper-coagulable state etc. 9 The prothrombotic states are protein C & protein S deficiency, activated protein C resistance, antithrombin III deficiency, elevated homocystiene level & abnormal lipid profile. The antiphospholipid syndrome, thrombocythemia & severe bacterial infection cause acquired hyper coagulable states. [9] [10] [11] [12] [13] Homozygous homocystinaemia accounts for 1 in 335 000 live births and is characterized by pre-mature vascular disease, thrombosis, mental retardation, skeletal abnormalities and lens disloca-tion. Heterozygous homocystinaemia is far more common, affecting up to 0.3-1% of the general populatnd is associated with recurrent deep venous thromboembolism. 14 Congenital protein C & protein S deficiencis are inherited disorders & the prevalence of protein C deficiency is 1 in 300 & that of protein S deficiency is less frequent than 1 in 1000. So the possibility of someone inheriting both deficiencies together is less than 1 in 300000, extremely rare. 15 Protein C and protein S systems are the major regulatory system of haemostasis. These proteins are vitamin K dependent proenzymes synthesized in the liver and become activated after binding to thrombinthrombomodulin complex on the surface of endothelial cells. Thus activated protein C inhibits factors VIIIa & Va. Here protein S acts as a cofactor & exhibiting their anticoagulant property. Acquired causes of these deficiencies are seen in liver disease, DIC, therapy with L-asparaginase, Coumarin & severe infections etc. 16 These deficiencies commonly present with DVT, account for nearly 90% of all venous thrombotic episodes & Pulmonary embolism. & thrombosis in other venous sides about 5% of cases. Chronic sequelae can be extremely debilitating because of the post-thrombotic syndrome that can affect up to 20 % of the patients. 17 Recurrent DVT can occur with. or without thrombophilic conditions , the highest risk being in the first 6 month. 18 Homocysteinaemia has been identified as an independent risk factor for coronary artery disease, peripheral vascular disease and thrombosis. Heterozygous homocysteina-emia has been recognized in up to 25% of patients with recurrent venous thrombosis. 14, 19 Doppler ultrasonography and venography although being regarded as the diagnostic ''gold standard",require a high level of training for the operator in order to be reliable.Venography is also an invasive procedure.Recently, the diagnosis of DVT has been improved by performing a probability test using the measurement of D-dimer levels (the products of fibrin degradation that increase with venous thromboembolism). 20 It is often make a fundamental error by testing for protein C & S deficiency when a patient is taking Coumarin (warfarin) or when they have had recent thrombotic event , as both of these causes protein C & S to be temporarily decreased So to confirm this deficiency, the patient must be off Coumarin for at least 14 days & must not have an active clotting episode in progress. So to confirm , we should repeat the test after 12 weeks & also testing the patient's first-degree relatives. 15 Hyperhomocysteinaemia appears to increa-and measurement of total fasting homocysteine levels alone can be misleading as it appears to misclassify 40% of patients.Conclusive results can be obtained using a moresensitive test by measurement of serum homocysteine levels before and after oral methionine loading. 19 The goals of treatment for DVT include halting clot formation & preventing recurrence of thrombi & PE. About 30% of DVT patient have a thrombophilia. The main stay of treatment was unfractionated heparin followed by warfarin. Out patient anticoagulant therapy is recommended for 3 to 6 month for VTE & for more than 12 month for recurrent VTE. 21 
Conclusion
So whenever a DVT of uncertain aetiology is suspected, it might have benefit from hypercoagulability testing because it is important to focus on inherited blood clotting problems. Except in the most severe cases, inherited problems are usually enough to cause DVT or pulmonary embolism on their own but this problems contribute to clot only when they are combined with environmental factors which activates the body's blood clotting machinery.If an inherited thrombophilia is diagnosed further screening and possible identification of other family members would lead to avoidance of known secondary risk factors and subsequent thrombo-embolic manifestations.
